Edition:
India

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
15 Dec 2017
Change (% chg)

$0.08 (+4.57%)
Prev Close
$1.75
Open
$1.80
Day's High
$1.88
Day's Low
$1.76
Volume
27,131
Avg. Vol
43,523
52-wk High
$2.29
52-wk Low
$0.78

Latest Key Developments (Source: Significant Developments)

Aptose Biosciences Files For Offering Of Up To 6 Mln Of Its Common Shares By The Selling Shareholder
Wednesday, 29 Nov 2017 

Nov 28 (Reuters) - Aptose Biosciences Inc ::APTOSE BIOSCIENCES INC FILES FOR OFFERING OF UP TO 6.0 MILLION OF CO'S COMMON SHARES BY THE SELLING SHAREHOLDER - SEC FILING‍​.  Full Article

Aptose Biosciences Inc Q3 loss per share C$0.14
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Aptose Biosciences Inc :Aptose reports results for the third quarter ended September 30, 2017.Q3 loss per share C$0.14.Aptose Biosciences Inc - ‍total cash and cash equivalents and investments as of September 30, 2017 were $13.6 million​.  Full Article

Aptose Biosciences Q2 loss per share C$0.46
Wednesday, 10 Aug 2016 

Aptose Biosciences Inc : Aptose biosciences reports financial results for the second quarter ended june 30, 2016 .Q2 loss per share c$0.46.  Full Article

Aptose Biosciences, CrystalGenomics sign cancer drug deal
Wednesday, 8 Jun 2016 

Aptose Biosciences Inc :Co and crystalgenomics says exclusive global option and license agreement focused on development of cg026806 (cg'806).  Full Article

Aptose Biosciences Q1 loss per share C$0.42
Wednesday, 11 May 2016 

Aptose Biosciences Inc : Q1 loss per share C$0.42 . Q1 earnings per share view C$-0.37 -- Thomson Reuters I/B/E/S .Aptose Bioscience reports results for the first quarter ended March 31, 2016.  Full Article

BRIEF-Aptose Biosciences Inc Q3 loss per share C$0.14

* Aptose reports results for the third quarter ended September 30, 2017